Drug Tariff News

MHRA Class 2 Drug Alert: Novartis - Agrippal suspension for injection in pre-filled syringe - Influenza Vaccine

The MHRA have issued a class 2 drug alert for:

Novartis Vaccines and Diagnostics S.r.l. - Agrippal suspension for injection in pre-filled syringe - Influenza Vaccine - EL (12)A/34

To view the alert please visit the MHRA website.

Posted 30 October 2012